Network Pharmacology Approach and Experimental Verification of Dan-Shen Decoction in the Treatment of Ischemic Heart Disease
Overview
Authors
Affiliations
Context: Dan-Shen Decoction, which is composed of Danshen, Tanxiang and Sharen, has a good therapeutic effect on ischemic heart disease (IHD). However, systematic research on the exact mechanism of action of Dan-Shen Decoction is still lacking. The anti-IHD effect of Dan-Shen Decoction was examined in this study using a systematic pharmacological method.
Objective: This study validates the efficacy and explores the potential mechanisms of Dan-Shen Decoction in treating IHD by integrating network pharmacology analyses and experimental verification.
Materials And Methods: The active components, critical targets and potential mechanisms of Dan-Shen Decoction against IHD were predicted by network pharmacology and molecule docking. H9c2 cells were pretreated with various 1 µg/mL Dan-Shen Decoction for 2 h before induction with 1000 µmol/L CoCl for 24 h. The cell viability was detected by CCK8, and protein expression was detected by western blots.
Results: The network pharmacology approach successfully identified 69 active components in Dan-Shen Decoction, and 122 potential targets involved in the treatment of IHD. The experiments indicate that the anti-IHD effect of Dan-Shen Decoction may be closely associated with targets such as AKT1 and MAPK1, as well as biological processes such as cell proliferation, inflammatory response, and metabolism.
Conclusions: This study not only provides new insights into the mechanism of Dan-Shen Decoction against IHD, but also provides important information and new research ideas for the discovery of anti-IHD compounds from traditional Chinese medicine.
Ahn C, Myong J, Ahmed K, Rahman M, Maharub Hossain Fahim M, Choi M Front Oncol. 2025; 15:1471110.
PMID: 39980567 PMC: 11841406. DOI: 10.3389/fonc.2025.1471110.
Chun-Peng Z, Tian C, Xue Y Heliyon. 2024; 10(13):e33308.
PMID: 39044965 PMC: 11263673. DOI: 10.1016/j.heliyon.2024.e33308.
Zhang Y, Wang T, Song Y, Chen M, Hou B, Yao B Heliyon. 2024; 10(6):e27646.
PMID: 38509951 PMC: 10950659. DOI: 10.1016/j.heliyon.2024.e27646.
Veerabaku M, Nithiyanantham J, Urooj S, Md A, Sivaraman A, Tee K Biomedicines. 2023; 11(4).
PMID: 37189784 PMC: 10135554. DOI: 10.3390/biomedicines11041167.